7/25/2019 ACS Patients

1/1

Studiul pacientilor cu SCA

CLINICALLY

PROVEN

Administrarea preparatuluiAtoris 40 mg/zisi-a demonstrat eficacitatea sain prevenirea rezultatelor ischemice severela pacientii cu SCA

Reducerea

incidena total a evenimentelor ischemice23!"

Reducerea

incidentei totale de moartalitate# I$ recurent %i a

an&inei 'recoce 'ost(in)arct!2"

2*+"Reducerea

duratei medii de accident cere,ro(vacular ischemic

Re)erence- Yalimov AA# .heh/an 00# 1adioncheno V. E))ect o) atorvastatin on li'id meta,olism# microcirculation# and dail/ EC0 monitorin& 'arameters in'atients ith acute coronar/ s/ndrome 4o'ical issues o) heart and vascular disease 255672839-+6:;2

A,revieri-

.CA : sindrom coronar acut# I$ : in)arct miocardic